Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

NCT03500731 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis
Emphysema or COPD

Interventions

BIOLOGICAL: CD3/CD19 negative hematopoietic stem cells
DRUG: Rituximab
DRUG: Alemtuzumab
DRUG: Fludarabine
DRUG: Thiotepa
DRUG: G-CSF
DRUG: Hydroxyurea

Sponsor

Paul Szabolcs